
With a market capitalization (market cap) of $3.74B — a measure of how much the company is worth — Vicore Pharma Holding AB is the 1600th most valuable company in Healthcare as of July 10, 2026. Shares trade at $13.30, down +4.42% on the day.
of 2,595
price ÷ annual EPS
Vicore Pharma Holding AB is a pharmaceutical company, which engages in the development of drugs with focus on interstitial lung diseases and related indications. Its drug development programs include VP01, VP02, VP03, and VP04. The company was founded in 2000 sand is headquartered in Stockholm, Sweden.
Visit websiteAs of July 10, 2026, Vicore Pharma Holding AB (VCRE) is worth $3.74B — this is its market capitalization, the total value of all its outstanding shares.
Vicore Pharma Holding AB’s market cap is $3.74B, which ranks it #1600 among the most valuable companies in the Healthcare sector tracked on MarketCapLens.
Vicore Pharma Holding AB (VCRE) shares trade at $13.30, down 4.42% on the day, as of July 10, 2026.
Fundamentals are annual. Figures labeled with their fiscal year.